Try it
Pharmacology · Neuromuscular junction: botulinum toxin
Sample itemA 45-year-old man with cervical dystonia receives botulinum toxin type A injections into the sternocleidomastoid, with relief for about three months. At the nerve terminal, what is the molecular action of the toxin?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Cleaves SNARE proteins such as SNAP-25, preventing acetylcholine vesicle fusion
Botulinum toxin is a zinc-dependent protease that is taken up into cholinergic terminals and cleaves SNARE proteins; type A cleaves SNAP-25. Without SNARE function, acetylcholine-containing vesicles cannot fuse with the membrane, causing flaccid paralysis until new terminals sprout. Clinical effect therefore wears off over months.
Option by option
A. Blocks postsynaptic nicotinic receptors competitively
Competitive nicotinic receptor blockade is the mechanism of non-depolarising blockers such as vecuronium.
B. Inhibits choline uptake into the nerve terminal
Inhibition of choline uptake is the action of hemicholinium, which is only an experimental tool.
C. Inhibits acetylcholinesterase at the junction
Acetylcholinesterase inhibition would increase, not reduce, junctional acetylcholine and is the action of neostigmine.
D. Cleaves SNARE proteins such as SNAP-25, preventing acetylcholine vesicle fusion (correct)
Cleavage of SNARE proteins abolishes exocytosis of acetylcholine, giving long-lasting chemodenervation.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?